Open Access:
A prospective real-world study over 2 years from Switzerland demonstrates sustained QoL benefits in individuals who use #erenumab for #migraine prevention
headachejournal.onlinelibrary.wiley.com/doi/full/10....
Andreas R. Gantenbein MD et al
A recent systematic & meta-analysis review failed to identify a correlation between #hypertension & #erenumab, & recommends additional studies, especially in high-risk groups
headachejournal.onlinelibrary.wiley.com/doi/full/10....
Luana Miyahira Makita et al
Open Access:
A medical claims database analysis finds no difference in the risk of vascular events in patients with #migraine treated with #erenumab vs other #CGRP mAbs vs #onabotulinumtoxinA
headachejournal.onlinelibrary.wiley.com/doi/full/10....
David W. Dodick MD et al
